204 related articles for article (PubMed ID: 6331644)
1. Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not by the noncarcinogenic congener benzo(e)pyrene.
White KL; Holsapple MP
Cancer Res; 1984 Aug; 44(8):3388-93. PubMed ID: 6331644
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the vitro humoral immune response of mouse splenocytes by benzo(a)pyrene metabolites and inhibition of benzo(a)pyrene-induced immunosuppression by alpha-naphthoflavone.
Kawabata TT; White KL
Cancer Res; 1987 May; 47(9):2317-22. PubMed ID: 3567925
[TBL] [Abstract][Full Text] [Related]
3. Benzo(a)pyrene metabolism by murine spleen microsomes.
Kawabata TT; White KL
Cancer Res; 1989 Nov; 49(21):5816-22. PubMed ID: 2507138
[TBL] [Abstract][Full Text] [Related]
4. Role of reactive metabolites in suppression of humoral immunity by N-nitrosodimethylamine.
Johnson KW; Munson AE; Kim DH; Holsapple MP
J Pharmacol Exp Ther; 1987 Mar; 240(3):847-55. PubMed ID: 3559977
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of murine splenic cell type metabolism of benzo[a]pyrene and functionality in vitro following repeated in vivo exposure to benzo[a]pyrene.
Ladics GS; Kawabata TT; Munson AE; White KL
Toxicol Appl Pharmacol; 1992 Oct; 116(2):258-66. PubMed ID: 1412470
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by polyaromatic hydrocarbons in mice and murine cells.
Blanton RH; Lyte M; Myers MJ; Bick PH
Cancer Res; 1986 Jun; 46(6):2735-9. PubMed ID: 3516385
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the metabolism and adverse effects of benzo[a]pyrene by a specific antibody: a novel host factor in environmental carcinogenesis?
De Buck SS; Bouche FB; Brandenburger A; Muller CP
Carcinogenesis; 2005 Apr; 26(4):835-44. PubMed ID: 15637092
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro immunosuppressive effects of benzo[k]fluoranthene in female Balb/c mice.
Jeon TW; Jin CH; Lee SK; Lee DW; Hyun SH; Kim GH; Jun IH; Lee BM; Yum YN; Kim JK; Kim OH; Jeong TC
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2033-50. PubMed ID: 16326422
[TBL] [Abstract][Full Text] [Related]
10. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules.
Shu HP; Bymun EN
Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698
[TBL] [Abstract][Full Text] [Related]
11. Detection of in vivo DNA repair synthesis in mouse liver and lung induced by treatment with benzo(a)pyrene or 4-nitroquinoline 1-oxide.
Kulkarni MS; Angerman-Stewart J; Anderson MW
Cancer Res; 1984 Apr; 44(4):1547-50. PubMed ID: 6322980
[TBL] [Abstract][Full Text] [Related]
12. The effect of humoral immunity against adducted benzo[a]pyrene on DNA damage elicited by acute carcinogen exposure in Swiss mice.
Galati R; Crebelli R; Zijno A; Conti L; Falasca G; Verdina A
In Vivo; 2000; 14(6):747-51. PubMed ID: 11204493
[TBL] [Abstract][Full Text] [Related]
13. Direct suppression of cultured spleen cell responses by chlordane and the basis for differential effects on in vivo and in vitro immunocompetence.
Johnson KW; Kaminski NE; Munson AE
J Toxicol Environ Health; 1987; 22(4):497-515. PubMed ID: 3694709
[TBL] [Abstract][Full Text] [Related]
14. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
Nakayama J; Yuspa SH; Poirier MC
Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
16. Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice.
Dean JH; Luster MI; Boorman GA; Lauer LD; Leubke RW; Lawson L
Clin Exp Immunol; 1983 Apr; 52(1):199-206. PubMed ID: 6305542
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts.
Feo F; Pirisi L; Pascale R; Daino L; Frassetto S; Garcea R; Gaspa L
Cancer Res; 1984 Aug; 44(8):3419-25. PubMed ID: 6331645
[TBL] [Abstract][Full Text] [Related]
18. Suppression of humoral antibody production by exposure to 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin.
Holsapple MP; McNerney PJ; Barnes DW; White KL
J Pharmacol Exp Ther; 1984 Dec; 231(3):518-26. PubMed ID: 6502511
[TBL] [Abstract][Full Text] [Related]
19. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
[TBL] [Abstract][Full Text] [Related]
20. Benzo[a]pyrene-induced immunotoxicity in Japanese medaka (Oryzias latipes): relationship between lymphoid CYP1A activity and humoral immune suppression.
Carlson EA; Li Y; Zelikoff JT
Toxicol Appl Pharmacol; 2004 Nov; 201(1):40-52. PubMed ID: 15519607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
